CPG
BSX icon

Cornerstone Planning Group’s Boston Scientific BSX Stock Holding History

Cornerstone Planning Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.3K Buy
518
+25
+5% +$1.36K ﹤0.01% 641
2026
Q1 		$27.6K Buy
493
+122
+33% +$9.76K ﹤0.01% 570
2025
Q4 		$34.8K Sell
371
-170
-31% -$16.7K 0.01% 434
2025
Q3 		$54.4K Buy
541
+225
+71% +$23.3K 0.01% 322
2025
Q2 		$33.1K Buy
316
+67
+27% +$6.78K 0.01% 310
2025
Q1 		$24.6K Buy
249
+50
+25% +$5.04K 0.01% 368
2024
Q4 		$20.4K Sell
199
-2
-1% -$176 0.01% 306
2024
Q3 		$17K Sell
201
-91
-31% -$7.17K ﹤0.01% 324
2024
Q2 		$21.3K Sell
292
-55
-16% -$4.03K 0.01% 307
2024
Q1 		$25.3K Hold
347
– – 0.01% 266
2023
Q4 		$20.1K Hold
347
– – 0.01% 316
2023
Q3 		$18.3K Buy
+347
New +$18.2K 0.01% 322

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cornerstone Planning Group's BSX Position: Q2 2026 in Review

Cornerstone Planning Group increased its Boston Scientific (BSX) stake by 5.1% in Q2 2026, buying an estimated $1.36K and bringing the position to 518 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #641.

Cornerstone Planning Group first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $54.4K in Q3 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cornerstone Planning Group held 518 shares of Boston Scientific worth $22.3K as of Q2 2026.
  • Cornerstone Planning Group bought 25 Boston Scientific shares in Q2 2026, an estimated $1.36K.
  • Boston Scientific made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #641 holding.
  • Cornerstone Planning Group first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • Cornerstone Planning Group's Boston Scientific position peaked at $54.4K in Q3 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.